Impacto de la Dextrina Resistente en la Glucosa Sanguínea y la Salud en los Singapurenses

Fecha de inicio: 14 de agosto de 2019

Inclusion Criteria: * 21 to 60 years old * Group A: 21 - 25 kg/m2, with first degree family history of type 2 diabetes, or Group B: 23 - 30 kg/m2, with waist circumference \>85 cm for males and \>82 cm for females Exclusion Criteria: * • Consume fibre supplements or any other supplements that is likely to interfere with study outcomes * Have any major organ dysfunction (e.g. cardiovascular, respiratory, hepatic, renal, gastrointestinal) that may influence taste, olfaction, appetite, digestion, metabolism, absorption or elimination of test foods, nutraceutical or drug * Smoking * Have any metabolic diseases (e.g. diabetes, hypertension) * Have medical conditions and/or taking medications known to affect glycaemia (e.g. glucocorticoids, thyroid hormones, thiazide diuretics) * Have glucose-6-phosphate dehydrogenase (G6PD) deficiency * Have any severe food allergy (e.g. anaphylaxis to peanuts), or any other known food allergy/intolerance * Have active Tuberculosis (TB) or currently receiving treatment for TB * Have any known Chronic infection or known to suffer from or have previously suffered from or is a carrier of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV) * A team member of the study or their immediate family members (i.e. spouse, parent, child, or sibling, whether biological or legally adopted) * Enrolled in a concurrent research study judged not to be scientifically or medically compatible with the study of the CNRC. * Intentionally restricting food intake * Have poor veins impeding venous access * Have any history of severe vasovagal syncope (blackouts or near faints) following blood draws * Have claustrophobia